Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.
Epicrispr Biotechnologies is a biotechnology enterprise that focuses on epigenetic engineering.
Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.
Pyxis Oncology is a biotechnology firm that develops antibody therapeutics intended to promote the body's immune response to cancer.
AN2 Therapeutics develops small-molecule medicines from boron chemistry for infectious diseases, hematologic disorders, and oncology.
Tare uses AI and tokenization to change the entire credit lifecycle.
Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.
Helus Pharma is a biopharmaceutical company that develops psychedelic therapeutics for mental health conditions.
Encoded Therapeutics is a biotechnology company developing genetic medicines for neurological disorders and other diseases.
Annexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.
Claris Biotherapeutics develops biologic therapies for corneal diseases and other disorders affecting the ocular surface.
Draig Therapeutics is a clinical-stage biopharmaceutical company that develops investigational therapies for neuropsychiatric disorders.
Wallbox is a technology company that provides electric vehicle charging and energy management solutions.
Neurogene is a developer of genetic medicines intended to improve patient outcomes for neurological disorders.
4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras.
Definium Therapeutics provides psychedelic-inspired medicines and therapies for substance abuse disorders and other mental illnesses.
Triveni Bio is a biotechnology company that develops antibody-based therapeutics for immunological and inflammatory diseases.
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.
Equillium is a biotechnology company that develops products for autoimmune and inflammatory disorders with an unmet medical need.
Longeveron is a biotechnology company that focuses on developing cellular therapies for chronic aging-related and life-threatening diseases.
Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.
Janus Henderson Investors has invested in 229 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Janus Henderson Investors's top investment sectors include Biotechnology, Health Care, Therapeutics, Life Science, Medical. The firm invests across 24 different industry categories.
Among tracked funding rounds, Definium Therapeutics received $805.0M in a Post-IPO Equity round. Janus Henderson Investors's total known invested capital is $34.7B.
Janus Henderson Investors's average investment size is $151.4M across its portfolio of 229 companies.
Recent Janus Henderson Investors portfolio additions include Star Therapeutics, Epicrispr Biotechnologies, Vaxcyte, Pyxis Oncology, AN2 Therapeutics. These companies were founded in 2020 or later.